Related Articles
TERT promoter mutations and their correlation with BRAF and RAS mutations in a consecutive cohort of 145 thyroid cancer cases
Comparison of diagnostic methods for the detection of a BRAF mutation in papillary thyroid cancer
Clinical significance of BRAF V600E mutation in 154 patients with thyroid nodules
Prognostic implications of the BRAF‑V600E mutation in papillary thyroid carcinoma based on a new cut‑off age stratification
BRAFV600E mutation is not associated with central lymph node metastasis in all patients with papillary thyroid cancer: Different histological subtypes and preoperative lymph node status should be taken into account